Heron Therapeutics Inc (HRTX)

EBITDA Margin

-18.53%

TTM · Period ending:

HRTX logo

HRTX EBITDA Margin

Latest reported-18.53%
HRTX TTM EBITDA Margin (-241.18% → -18.53%)
High-resolution chart · PNG

HRTX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-18.5318%
-16.4214%
-8.7028%
-2.147%
4.598%
0.3091%
-3.5589%
-14.1211%
-28.8946%
-54.9035%
-80.8137%
-98.9458%
-117.8583%
-134.7589%
-171.3658%
-216.9351%
-235.5399%
-254.263%
-250.7331%
-256.2205%
-273.475%
-266.3976%
-251.0549%
-209.5824%
-153.3135%
-135.3069%
-137.861%
-138.1081%
-171.1364%
-192.0633%
-225.4369%
-328.9454%
-405.6247%
-505.5708%
-627.3832%
-807.4524%
-1,307.3711%
-3,325.1256%
-8,730.9278%
-23,275.4917%
-675.2068%
-584.5422%
-435.7143%
-325.8963%
-5,710.757%
-1,684.6749%
-1,029.2121%
-512.3299%
-561.512%
-746.1184%
-806.8328%
-476.7164%
-657.0281%
-783.981%
-1,000.0862%
-15,557.9439%
-7,721.2245%
-6,224.8649%
-5,619.7505%
-4,850.5576%
-4,391.5751%
-5,584.9879%
-7,496.0854%
-12,305.625%
-1,055.2632%
-475.1528%
-274.0263%
-147.3567%
-145.0359%
-142.7207%
-138.5924%
-167.7831%
-155.3598%
-145.4617%
-140.1788%
-126.8509%
-91.3091%
-96.4337%
-88.4061%
-76.2895%
-115.1762%
-134.0436%
-141.3862%
-152.7797%
-170.7611%
-146.6296%
-137.8681%
-60.0691%
-7.1338%
-4.7833%
2.4212%
8.9157%
13.5052%
20.6186%
20.7071%
19.1919%
12.5%
8.6957%
3.9326%
5.4945%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.